Who is sponsoring NCT04964180?

NCT04964180 is sponsored by South Valley University.

What drugs are being tested in NCT04964180?

Interventions in NCT04964180: Indomethacin suppository, Lidocaine 2% Injectable Solution.

What condition does NCT04964180 study?

NCT04964180 studies Post-Operative Pain.

Is NCT04964180 still recruiting?

NCT04964180 is currently completed. Last updated 15 July 2021.

Last reviewed 2021-07-15 · How we verify

NCT04964180

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Completed NA Last updated 15 July 2021

What this trial tests

NA trial testing Indomethacin suppository in Post-Operative Pain in 80 participants. Completed in 20 June 2021.

Timeline

1 May 2020

Primary endpoint
30 May 2021

20 June 2021

Quick facts

Lead sponsor	South Valley University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	1 May 2020
Primary completion	30 May 2021
Estimated completion	20 June 2021
Sites	1 location across Egypt

Drugs / interventions tested

Indomethacin suppository — full drug profile →
Lidocaine 2% Injectable Solution — full drug profile →

Conditions studied

Post-Operative Pain — all drugs for Post-Operative Pain →

Sponsor

South Valley University

Who can join

Adults 18 to 60, any sex, with Post-Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hospitals, Qena, Egypt in period between May 2020 to May 2021.eighty patients was scheduled to elective laparoscopic cholecystectomy , divided Into two groups randomly using closed envelop method. Group IP lidocaine(40 patients ) received 200 ml saline containing 200 mg 2%lidocaine immediately after abdominal cO2 insufflation( pneumoperitoneum) the surgeon sprayed the total solution on the upper surface of the liver under the right subdiaphragmatic space, left subdiaphragmatic space and around the cholecystectomy site , all patients were maintained in trendelenberg position. At the end of the laparoscopic procedure, group indomethacin (40 patients) recived two 100 mg indomethacin rectal suppositories 2 hours prior to surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Indomethacin suppository

Trials testing the same drug.

NCT06623513 — Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis · Phase 2 · not yet recruiting
NCT05722548 — Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis · Phase 2 · unknown
NCT05381428 — Prophylaxis of Post-ERCP Acute Pancreatitis · Phase 3 · completed
NCT05109143 — Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy · NA · completed

Other South Valley University trials

Trials by the same sponsor.

NCT07478718 — Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy · NA · not yet recruiting
NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
NCT07070544 — Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure · NA · not yet recruiting
NCT07128472 — Evaluation of IL 12B Genetic Polymorphism (rs3213094) · NA · recruiting
NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04964180 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by South Valley University
Last refreshed: 15 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04964180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing